Moderna (MRNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

Moderna ($MRNA) stock jumped 17% on Thursday, fueled by speculation of potential buyout talks amid concerns over declining ...

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.5% in the afternoon session after the stock ...

Recently, Zacks.com users have been paying close attention to Moderna (MRNA). This makes it worthwhile to examine what the stock has in store.

This Nasdaq biotech in my Stocks and Shares ISA portfolio just got a shot in the arm. Here's why I'm almost past caring at this point. The post Up 14% yesterday, is it the end for this train wreck in ...

Investing.com -- 4basebio PLC (AIM:4BB) stock surged 6.9% on Monday after announcing that a global Tier 1 pharmaceutical partner has begun dosing patients in Phase I/II clinical trials using the ...

Durban-headquartered pharmaceutical major Aspen Pharmacare confirmed in a Sens announcement on Friday that it has reached a ...

ResMed (RMD) is scheduled to announce Q1 earnings results on Thursday, October 30th, after market close. The consensus EPS Estimate is $2.50 (+13.6% Y/Y) and th ...

A social media giant faltered on Thursday, Oct. 30, 2025, as a tax event weighed on its results, while a biotech name benefitted from reports of talks with a major pharma player.

Shares of biotechnology company Wave Life Sciences rose as it held its Annual Research Day, detailing its work in RNA editing and RNAi for conditions including Alpha-1 antitrypsin deficiency and ...

Gavin Newsom, Anna Wintour, Doja Cat and a handful of Hollywood stars came to celebrate Tinseltown and all its fashion.

The democratization of investing started with discount brokers slashing commissions and advanced through no-transaction-fee ...